Commercial
  
MPNewsFlashTopicPub
MPPurposePub
  
  
  
  
11/25/2020
Notice of Withdrawal of Advance Notification of Future Policy #00.10.41h: Telemedicine Services (Independence)

The purpose of this communication is to provide notice that Advance Notification of future Policy​ #00.10.41h: Telemedicine Services (Independence)​ has been withdrawn from the Medical Policy Portal.
0Notice of Withdrawal of Advance Notification of Future Policy #00.10.41h: Telemedicine Services (Independence)83a7cfbd-7329-4606-adb9-2f8e7b8ba399
11/25/2020
Veklury® (remdesivir) and Bamlanivimab® (LY-CoV555) for COVID-19 Treatment for Independence Commercial Members


To Communicate the Company's coverage position for Veklury® (remdesivir) and Bamlanivimab® (LY-CoV555) for COVID-19 treatment for the Company's Independence Commercial products.  ​


This communication addressing Treatments for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) is effective from October 22, 2020 through March 31, 2021, or the duration of the public health emergency.



0Veklury® (remdesivir) and Bamlanivimab® (LY-CoV555) for COVID-19 Treatment for Independence Commercial Members30d295db-0e4c-4488-8652-e15718e0fdd0
10/6/2020
Testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for Commercial Independence Members
The purpose of this News Article is to provide advance notice regarding information and procedure and diagnosis codes related to testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for Commercial Independence members​.

1Testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for Commercial Independence Membersb8f3ff0c-fd9c-436d-b0f5-9d6337bb445e
10/1/2020
10/1/2020 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products
The intent of this article is to communicate Commercial Product coverage determinations for services identified through the Quarterly Code Update process. The procedure codes that represent these services will become effective on 10/1/2020, unless otherwise noted.

For more information related to these services, please refer to specific policies when applicable.​

110/1/2020 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Productsc322926f-ec73-4821-aac6-943615dd055a
7/17/2020
Consumer Grade Pulse Oximetry Devices For Use In The Home Setting
The purpose of this News Article is to provide advance notice during the COVID-19 outbreak related to the coverage of consumer grade pulse oximetry devices for use in the home setting.
1Consumer Grade Pulse Oximetry Devices For Use In The Home SettingC8D6FA9AF15929A88525857E004FAA79
7/17/2020
Respiratory Equipment and Related Supplies (updated July 17, 2020)
The purpose of this News Article is to provide advance notice during the COVID-19 outbreak related to respiratory equipment and related supplies.
1Respiratory Equipment and Related Supplies (updated July 17, 2020)A957C168AD6F9248852585A700776FBF
7/17/2020
Coverage of Vaxelis, diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, inactivated poliovirus, Hemophilus b conjugate and Hepatitis B vaccine
The purpose of this NewsFLASH is to provide notice regarding updated coverage information for diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, inactivated poliovirus, Hemophilus b conjugate and Hepatitis B vaccine for individuals enrolled in the Company's Commercial Products.
1Coverage of Vaxelis, diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, inactivated poliovirus, Hemophilus b conjugate and Hepatitis B vaccine6D57F80CD373240D852585A8006DEE06
7/1/2020
7/1/2020 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products
17/1/2020 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products5D38243F686BE26685258598006308EB
5/19/2020
Telemedicine Services for Independence Commercial Members (Updated May 19, 2020)
The purpose of this News Article is to provide advance notice regarding coverage for telemedicine services for our Independence commercial members in response to Coronavirus Disease 2019 (COVID-19).
1Telemedicine Services for Independence Commercial Members (Updated May 19, 2020)9AB657A6E78A82CE8525856C007495F4
5/12/2020
Pharmacologic Nuclear Stress Testing in Response to COVID-19
The purpose of this News Article is to provide advance notice regarding the use of pharmacologic stress testing with nuclear imaging in response to the Public Health Emergency (PHE) for the COVID-19 pandemic.
1Pharmacologic Nuclear Stress Testing in Response to COVID-195A7DE68A793E25EB852585650075011A
1 - 10Next